Final Program

MONDAY • MAY 16 187
P37
P38
P39
P40
P41
P42
P43
P44
P45
P46
P47
Endostatin and Right Ventricular Remodeling in PAH/R.L.
Damico, A. Goyanes, L. Varela, C.P. Corona-Villalobos, S.L.
Zimmerman, S.C. Mathai, T. Kolb, P.M. Hassoun, Baltimore, MD,
p.A3907
Examination of the CXCL11/CXCR3 Biological Axis in the
Hypoxic Lung/C. Hughes, M. Paterson, P. McLoughlin, C.
Costello, Dublin, Ireland, p.A3908
HIV-Nef-Induced Apoptosis in Lung Microvascular Endothelial
Cells Correlates with the Upregulation of EMAPII/S.
Chelvanambi, M. Clauss, R.B. Day, H. Twigg, Indianapolis, IN,
p.A3909
Reversal of Pulmonary Arterial Hypertension by a Taxane
Anti-Tumor Drug/Y.F. Ibrahim, Y.J. Suzuki, Washington, DC,
p.A3910
Kinetic Analysis of 3’-Deoxy-3’-[18F]-Fluorothymidine (FLT)
Positron Emission Tomography (PET) in
Monocrotaline-Induced Pulmonary Hypertension Rat/A. Ashek,
O. Dubois, M. Wilkins, L. Zhao, London, United Kingdom, p.A3911
IW-1973, a Clinical-Stage Soluble Guanylate Cyclase
Stimulator, Affects Pulmonary Hemodynamics and Attenuates
Inflammation and Vascular Damage to the Lungs in a
Monocrotaline-Induced Pulmonary Arterial Hypertension Rat
Model/S. Jacobson, D.P. Zimmer, C. Shea, M. Currie, J. Masferrer,
Cambridge, MA, p.A3912
Effects of Inhaled Nitric Oxide on Pulmonary Artery Smooth
Muscle Cells (PASMC) Exposed to Positive Pressure
Ventilation and Hyperoxia/D. Alapati, S.L. Balasubramaniam, J.
Hossain, S. Soundar, P. Fawcett, T.H. Shaffer, Wilmington, DE,
p.A3913
Hydrogen Sulfide (H2S) Prevents the Monocrotaline Induced
Pulmonary Hypertension by Regulating Inflammasome
Signaling/A.K. Baidya, A. Chhabra, V. Chhabra, S.M. Malik, S.B.
Singh, M. Sharma, P. Reddy, New Delhi, India, p.A3914
Abrogation of Endothelial Mef2c Results in Exacerbation of
Pulmonary Hypertension: Implicating the Histone Deacetylase
(HDAC) IIa-MEF2 Signaling Axis/A. Sofer, C. Hwangbo, I.
Papangeli, X. Hu, S. Park, J. Schwarz, H. Chun, New Haven, CT,
p.A3915
Investigation of Neutrophil Function in IPAH Patients/M.-H.
Ruchaud-Sparagano, J. Grant, L. Thirugnanasothy, S.
Sithamparanathan, J. Simpson, P. Corris, Newcastle upon Tyne,
United Kingdom, p.A3916
S100A12 is Elevated in Patients with Pulmonary Hypertension
and Predicts Mortality/C. Ryu, A.E. Tzouvelekis, J. Herazo-Maya,
H. Pan, P. Adonteng-Boateng, Q. Li, N. Kaminski, H.J. Ford, F.
Ahmad, E. Herzog, W.H. Fares, New Haven, CT, p.A7832
B54
THEMATIC POSTER SESSION
CASE REPORTS IN THE PULMONARY
CIRCULATION
9:00 a.m. - 4:15 p.m. MOSCONE CENTER
Viewing: Posters will be on display for entire session.
Area A, Hall D (North Building, Lower Level)
Discussion: 11:00-11:45: authors will be present for individual discussion
11:45-12:45: authors will be present for discussion with assigned facilitators
Facilitator:
P49
P50
P51
P52
P53
P54
P55
H.I. Palevsky, MD, Philadelphia, PA
Pulmonary Arterial Hypertension Caused by Congenital
Portosystemic Venous Shunt: A Case Report/X. Cheng, C.
Xiong, Beijing, China, p.A3917
Pulmonary Thromboembolism with Right Heart
Thrombus-in-Transit: Vital Bedside Diagnosis Using Goal
Directed Echocardiography to Guide Emergent Management/I.
Kourouni, S.R. Dudekonda, J. Mathew, N. Gopal, J. Shapiro, New
York, NY, p.A3918
Pulmonary Capillary Hemangiomatosis: A Rare Cause of
Pulmonary Hypertension/E. Demirer, T. Caliskan, F. Ciftci, Z.
Kucukodaci, M. Yalcin, E. Ozturk, K. Kara, I. Yilmaz, Istanbul,
Turkey, p.A3919
Hereditary Hemorrhagic Telangiectasia (Rendu-Osler-Weber
Syndrome): Unusual Presentation and Follow Up with
CPET/C.A. Celis Preciado, J. Lasso, D. Ballen, C. Zuluaga, A.
Romero, D. Valencia, Bogota, Colombia, p.A3920
Hepatopulmonary Syndrome in Hereditary Hemorrhagic
Telangiectasia (HHT): Not All Right-to-Left Shunting in HHT Is
Due to Pulmonary Arteriovenous Malformations/S. Krishnan, T.
Lahm, Indianapolis, IN, p.A3921
What Really Came First, the Disease or the Manifestations?/I.
Valle, R. Fernandez-Gonzalez, M. Cruz Caliz, A. Dones, Rio
Piedras, PR, p.A3922
Paradoxical Embolism Due to Pulmonary Arteriovenous
Malformation (PAVM) Causing Acute Ischemic Stroke During
Systemic Thrombolytic Therapy for a Massive Pulmonary
Embolism (PE)/M. Ijaz, M. Hasan, H. Khaleel, J.-T. Chen, Bronx,
NY, p.A3923
P56 Systemic Vascular Invasion Causing Hemoptysis/T. Cheng, V.
Chen, San Jose, CA, p.A3924
P57
A Rare Case of a Primary Sarcoma of the Pulmonary Artery in
a 56 Year Old Female: A Case Report/E. Leung, M. Salih, N.
Ettinger, Chesterfield, MO, p.A3925
MONDAY MORNING
P58
A Case of Pulmonary Artery Aneurysm - A Rare and
Dangerous Entity/G.F. Shaughnessy, B.P. Shapiro, Jacksonville,
FL, p.A3926
P59
Acute Pulmonary Embolism Presenting as a Lung Mass/M.
Yaqoob, M. Hundal, C. Ghattas, J. Unterborn, Brighton, MA,
p.A3927
ATS 2016 • San Francisco